TikTok Influencers Driving Parallel Market for Unlicensed Weight-Loss Drug

An underground market for unlicensed slimming medications is being driven by TikTok fitness influencers and sellers on messaging platforms, based on new investigations.

Experimental Treatment Gaining Popularity Online

The experimental drug, which remains in research studies, is being advertised by social media influencers for its alleged fat-burning properties. Viewers are urged to contact these profiles privately for supplier links, while also obtaining discount codes.

Active Commerce on Social Networks

Additionally, a robust market exists on messaging services, where groups with thousands of participants share “before and after” images, injection guides and claims of next-day British shipping. Sellers promote the drug there before directing buyers to WhatsApp for purchases.

Learning About Retatrutide

This medication is an investigational injection created by US drugmaker Eli Lilly. The drug affects three gut hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies indicate it could assist individuals reduce up to 25% of their body weight. Referred to as the “triple G”, the drug is being promoted online as the successor to Ozempic.

Medical Professionals Voice Worries

However, doctors and pharmacists have warned that the sale of what remains an unlicensed drug in the UK is a cause for concern and could lead to individuals administering products of unknown origin.

Several professionals stated the demand for the experimental drug could be linked to the rising cost of licensed weight loss products such as Mounjaro.

Legal Status and Implementation

Selling the unapproved drug on TikTok or Telegram is prohibited in the UK, as it is an unlicensed drug that must not be promoted or supplied for human use under the Human Medicines Regulations 2012.

Some content creators attempt to sidestep the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and distribution can still violate pharmaceutical, advertising, and customer laws, potentially leading to fines, legal action or imprisonment.

Service Response and Content Removal

According to TikTok, the platform has taken down violative material and prohibited related hashtags and query recommendations. The company stated it was committed to keeping the platform secure and allocating resources in strengthening compliance measures.

Digital Trading Activities

Research also discovered groups with up to 9,000 members selling retatrutide using the platform's integrated search feature, which operates like a online catalog. Entering “retatrutide” instantly brings up channels with numerous of members, populated with images of weight loss, glowing reviews and detailed instructions for mixing or injecting at residence.

Within moments of joining one community, a seller shared contact information, where most transactions occur. The seller provided an instruction manual and promised delivery within 48 hours. When questioned whether the product was genuine, one vendor said: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. None asked about weight, medical conditions or previous experience.

Item Details and Pricing

Inside these groups, messages show dark colored parcels with Royal Mail labels, stating to contain new batches. One communication stated: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, mixed at residence with purified liquid, or pre-filled injectors usually priced at £160 for 20mg. When asked how long a pen should be used, vendors give contradictory answers ranging from a few weeks to “depends on your body”.

Platform Oversight and Security Actions

A spokesperson for the messaging service stated it actively moderated harmful content on its service including material that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“Individuals are injecting substances they can’t verify. Even if the science behind this drug is valid, these online products may not include what they claim,” said Jason Murphy, the director of pharmaceutical services at Chemist4U.

A medical professional of an online medical service linked the increase in demand to recent price rises for approved slimming medications such as Mounjaro. “With prices rising, patients are using online platforms. But counterfeit injections are highly risky. You can’t be certain what’s contained or whether the environment they were produced in was clean,” she explained.

Her team has previously encountered patients injured by self-injection from unverified suppliers. “We recognize the frustration, but purchasing from messaging apps or WhatsApp is taking chances with your well-being,” stated the doctor. “These substances could be contaminated or improperly measured.”

Manufacturer Position

A representative from Eli Lilly said retatrutide was in phase 3 clinical trials and had not been evaluated or approved by any government authority anywhere in the world. “Therefore at this point no one can market [it] for personal consumption,” they said, noting that any product “misleadingly claiming itself as a company investigational substance not yet authorized … may subject users to potentially significant health risks”.